Alexander Litke

Summary

Affiliation: Kantonsspital Aarau
Country: Switzerland

Publications

  1. doi The potential impact of biomarker-guided triage decisions for patients with urinary tract infections
    A Litke
    Medical University Department of the University of Basel, Kantonsspital Aarau, Tellstrasse, 5001, Aarau, Switzerland
    Infection 41:799-809. 2013
  2. pmc Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
    Werner C Albrich
    University of Basel, Kantonsspital Aarau, Aarau
    Eur Respir J 42:1064-75. 2013
  3. pmc Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial
    Daniel Drozdov
    Medical University Department, University of Basel, Kantonsspital Aarau, Tellstrasse, Aarau 5001, Switzerland
    Trials 14:84. 2013

Detail Information

Publications3

  1. doi The potential impact of biomarker-guided triage decisions for patients with urinary tract infections
    A Litke
    Medical University Department of the University of Basel, Kantonsspital Aarau, Tellstrasse, 5001, Aarau, Switzerland
    Infection 41:799-809. 2013
    ..We evaluated the currently used triage routine and tested whether a set of criteria including biomarkers like proadrenomedullin (proADM) and urea have the potential to improve triage decisions...
  2. pmc Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
    Werner C Albrich
    University of Basel, Kantonsspital Aarau, Aarau
    Eur Respir J 42:1064-75. 2013
    ..13). There were no differences in adverse outcomes or readmission. Logistic obstacles and overruling are major challenges to implement biomarker-enhanced algorithms in clinical settings and need to be addressed to shorten length of stay...
  3. pmc Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial
    Daniel Drozdov
    Medical University Department, University of Basel, Kantonsspital Aarau, Tellstrasse, Aarau 5001, Switzerland
    Trials 14:84. 2013
    ..Second, for Intervention B, it investigates the usefulness of the prognostic biomarker proadrenomedullin (ProADM) integrated into an interdisciplinary assessment bundle for site-of-care decisions...